Psilocybin (magic mushrooms) used by Charles Grob In Psychiatry - Good Idea?

  • Context: Medical 
  • Thread starter Thread starter aspergers@40
  • Start date Start date
  • Tags Tags
    Idea
Click For Summary
SUMMARY

The discussion centers on the potential use of psilocybin, a psychedelic compound found in magic mushrooms, in psychiatric treatment, particularly as explored by Dr. Charles Grob. While there are anecdotal success stories, the legal status of psilocybin as a Schedule I substance in the U.S. complicates its use in clinical settings. The conversation highlights the challenges of proving efficacy through double-blind studies and the significant placebo effect observed in psychotherapy. Additionally, the potential of other substances like MDMA and ketamine in treating mental health conditions is noted, emphasizing the need for more research in this area.

PREREQUISITES
  • Understanding of psychedelic substances and their classifications, such as Schedule I.
  • Familiarity with the placebo effect and its implications in psychotherapy.
  • Knowledge of clinical trial methodologies, particularly double-blind studies.
  • Awareness of current research on MDMA and ketamine in mental health treatment.
NEXT STEPS
  • Research the latest studies on psilocybin and its therapeutic applications in psychiatry.
  • Explore the legal landscape surrounding the use of MDMA in therapeutic settings.
  • Investigate the efficacy of ketamine as a rapid treatment for depression.
  • Learn about the role of empathogens in psychotherapy and their potential benefits for conditions like Asperger's syndrome.
USEFUL FOR

This discussion is beneficial for mental health professionals, researchers in psychedelic therapy, and individuals interested in alternative treatments for psychiatric conditions.

aspergers@40
Messages
61
Reaction score
0
I was intrigued when I read about this and the many success stories that he's had with his patients. Is this a valuable yet underused medical treatment in your opinion? Dr. Charles Grob - Psychedelic Researcher
 

Attachments

  • CharlieGrob.jpg
    CharlieGrob.jpg
    12.1 KB · Views: 439
Biology news on Phys.org
The only use for magic shrooms that I know of, offlabel, is for cluster headaches
 
Not in the US. It is a scheduled I substance which means it has no redeeming medical value whatsoever.

Numerous psychotherapists and researchers have enjoyed considerable success with unapproved methods. And really I should not imply that such success is limited to issues of the mind. Does laying on of hands help, twirling psychic energy, acupuncture, homeopathy, and a very long list?

I don't want to seem pedantic here; we are all familiar with the placebo effect. We are also aware of the biases which insinuate themselves into any therapist/patient relationship. Besides the placebo effect, the therapist (hopefully) believes in the therapy offered and is more likely than not to see a favorable influence. Patient, so encouraged, believes to be better, and you get this nice positive feedback summoning the patient towards improvement. The other effect you will see is the people pleasing effect--some patients are either naturally people pleaers, or become like a pet student who want to be the a+ student become so engaged with apparent improvement, they actually do...via a placebo like effect or for lack of a better term, fake it til you make it--the increased engagement with life and activity revive the pleasure pathways, and the brain bbenefits from the stimulation.

I am aware of Grob's work while I believe it was conducted in a scrupulous and most conscientious fashion, still wonder to what extent these warning I mentioned might apply. Forgive a bad pun, but the acid test of any intervention is a double blinded study where neither the observer or the subject knows what's up. They do this with any psychoactive drug before it gets to market.

With antidepressants like Prozac the separation is not that great. Placebo response is about 30%, active drug maybe 50%.

So getting back to your question--how do you administer a hallucinogen vs a placebo?

I don't discount this research whatsoever. It is just a sticky wicket to prove efficacy and with a fear of such modalities dating back to "reefer madness", you have a tough sale to get permission to do so. Things have loosened up a bit since Reagan but still a tough road to hoe. There are a couple of exceptions I can look up if interested.

Maybe the one iilegal drug with the most untapped potential for psychotherapy is something like Ecstasy. This was widely used in the bay area and other sites in the late 70' and early 80's. Therapists were reporting astonishing results with very difficult to treat patients in individual and marital counseling.

So that's the state of things--potentially promising therapies are outlawed for fear of abuse potential and adverse side effects, and in many cases, no way of assessing theirr itherapeutic impact without the non-doubleblind situation issues requiring very good study designs.

Liability issues are rampant, professional credibility will be forsaken in most quarters, why bother?? Personally, I feel the greatest potential loss is with ketamine. It has been shown to bring about VERY rapid resolution of depression yet, it can be abused, is lethal in overdose... Much like any garden variety pain reliever. ?? I doubt any opiate could pass current FDA standards if discovered yesterday.
 
Thanks for the input, much appreciated. I read about it in Discover Magazine of the Brain, and the report seemed quite favourable, with six new studies involving MDMA, acid etc. I find marijuana as a good passifier of my asperger's anxiety. Like you say, it's a question of delicate balance. I would be a willing guinea-pig for the psilocybin incidentally. Any relief from particularly acute symptoms shouldn't be denied from patients imo.
 
I'll have to find the issue. I would be particularly interested to see whether MDMA has been in tried with connection of Aspergers patients. MDMA and simuilar compounds are as far as I know the only known chemical empathogens, and may be of great value in developing these capacities. Come to think of it, I know a few CEO's, aka sociopaths, who might benefit from such.
 
denverdoc said:
I'll have to find the issue. I would be particularly interested to see whether MDMA has been in tried with connection of Aspergers patients. MDMA and simuilar compounds are as far as I know the only known chemical empathogens, and may be of great value in developing these capacities. Come to think of it, I know a few CEO's, aka sociopaths, who might benefit from such.
lol.
 

Similar threads

Replies
1
Views
3K
Replies
1
Views
2K
  • · Replies 1 ·
Replies
1
Views
2K
  • · Replies 2 ·
Replies
2
Views
2K
  • · Replies 47 ·
2
Replies
47
Views
10K
  • · Replies 2 ·
Replies
2
Views
4K
  • · Replies 6 ·
Replies
6
Views
5K
  • · Replies 11 ·
Replies
11
Views
41K
  • · Replies 8 ·
Replies
8
Views
9K
  • · Replies 2 ·
Replies
2
Views
3K